The European and Developing countries Clinical Trials Partnership 2 (EDCTP2) opened the first call for research proposals.
The call invites proposals for research on validation of the clinical performance and/or implementation of new or improved diagnostic tools and technologies for detection of any of the PRDs, including as co-infections.
These tools and technologies should improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes.
Applications should focus on late stage development (e.g. evaluation and/or demonstration phase trials) or implementation studies in sub-Saharan Africa. Applications should further provide detailed plans for World Health Organisation (WHO) endorsement and/or implementation of the diagnostic tools and technologies upon successful completion of the project. Proposals focused entirely on early-stage, laboratory-based studies using biobanked samples are outside the scope of this call. Priority will be given to point-of-care diagnostics for use in resource-limited settings.
Further information for this 2-stage-call (deadline stage 1: 2nd March 2015) on eligibility, expected impact etc. can be found under:Nike Air Force 1